BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Jiang Z, Wu Y, Gong W, Liao X, Li X. Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel. Front Oncol 2022;12:935817. [DOI: 10.3389/fonc.2022.935817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 . Gimeracil/oteracil/tegafur/paclitaxel. Reactions Weekly 2022;1923:233-233. [DOI: 10.1007/s40278-022-23096-4] [Reference Citation Analysis]